Benchmark Starts Symmetry Medical (SMA) at Hold; Business in Transition
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Price: $9.27 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Benchmark initiates coverage on Symmetry Medical (NYSE: SMA) with a Hold. PT $10.00.
Analyst, James Terwilliger, said, "We are encouraged by the changes at SMA with a business transition from an OEM to that of a company that sells direct with more proprietary products. We believe that the new CEO (Thomas Sullivan) is putting his mark on the company with the Codman acquisition..."
However, Terwilliger sees the business in transition this year and due to the acquisitions in the second half of 2011, management is focused on the balance sheet and reducing debt.
For an analyst ratings summary and ratings history on Symmetry Medical click here. For more ratings news on Symmetry Medical click here.
Shares of Symmetry Medical closed at $8.61 yesterday.
Analyst, James Terwilliger, said, "We are encouraged by the changes at SMA with a business transition from an OEM to that of a company that sells direct with more proprietary products. We believe that the new CEO (Thomas Sullivan) is putting his mark on the company with the Codman acquisition..."
However, Terwilliger sees the business in transition this year and due to the acquisitions in the second half of 2011, management is focused on the balance sheet and reducing debt.
For an analyst ratings summary and ratings history on Symmetry Medical click here. For more ratings news on Symmetry Medical click here.
Shares of Symmetry Medical closed at $8.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
- Northland Starts Life Time Group Holdings Inc (LTH) at Outperform
- Truist Securities Starts Insmed (INSM) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
